We use cookies to collect anonymous data to help us improve your site browsing experience.

Click 'Accept all cookies' to agree to all cookies that collect anonymous data. To only allow the cookies that make the site work, click 'Use essential cookies only.' Visit 'Set cookie preferences' to control specific cookies.

Set cookie preferences

Your cookie preferences have been saved. You can change your cookie settings at any time.

Publication - Regulation/directive/order

Coronavirus (COVID-19) vaccine - Comirnaty® 10 micrograms/dose (mRNA, Pfizer/BioNTech): national protocol v1.0

Published 14 March 2022
Directorate
Covid Co-ordination Directorate
Part of
Coronavirus in Scotland, Health and social care, Public safety and emergencies
ISBN
9781804351796

Protocol for the supply and administration of Comirnaty® 10 micrograms/dose (COVID-19 mRNAVaccine, Pfizer/BioNTech) national protocol v1.0.

View supporting documents Supporting documents

5. Clinical condition or situation to which this Protocol applies

Comirnaty® 10 micrograms/dose (COVID-19 mRNA Vaccine, Pfizer/BioNTech) is indicated for active immunisation against COVID-19 disease caused by SARS-CoV-2 virus in accordance with Scottish Government COVID-19 immunisation programme and recommendations given in Chapter 14a of the Immunisation Against Infectious Disease: the ‘Green Book’ COVID-19: the green book, chapter 14a - GOV.UK (www.gov.uk) and Scottish Government CMO letters relating to COVID-19 vaccination.

Contact

Email: CEU@gov.scot

Back to top